FDAClass IIJune 26, 2024

Amoxicillin and Clavulanate Potassium Tablets USP recall: Subpotent

Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in Canada By: Teva Canada Limited…

Why was Amoxicillin and Clavulanate Potassium Tablets USP recalled?

Subpotent Drug

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot #: 100047634 Exp. Date 4/2025; 35449379A, Exp. Date 7/2024

Product
Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in Canada By: Teva Canada Limited…
Recalling firm
Teva Pharmaceuticals USA, Inc
Quantity
34,448 bottles
Distribution
Nationwide within the United States
Recall date
June 26, 2024
Classification
Class II
Status
Ongoing
Agency
FDA (drug)
Open FDA enforcement record Latest recalls